Clinical Practice Perspectives on Treatment of MM with Bispecifics
Before closing out their discussion on multiple myeloma management, panelists reflect on real-world clinical practice perspectives on treatment with bispecifics.
Selecting and Sequencing Bispecifics and CAR-T Therapies in R/R MM
A review of novel treatment modalities for relapsed/refractory multiple myeloma, with a focus on selecting and sequencing bispecific antibodies and CAR T-cell therapies.
Patient Case 3: Relapsed/Refractory Multiple Myeloma
Expert panelists center discussion on a final patient case to review the identification and management of relapsed/refractory multiple myeloma.
Treatment Strategies for Patients With Transplant-Ineligible NDMM
Expert perspectives on selection of induction therapy for patients with transplant-ineligible newly diagnosed multiple myeloma.
Patient Case 2: Transplant-Ineligible Newly Diagnosed Multiple Myeloma
Panelists move on to review a patient case of transplant-ineligible newly diagnosed multiple myeloma and highlight clinical workup strategies.
Optimal Selection of Therapy for Patients With Transplant-Eligible NDMM
A focused discussion on navigating the treatment armamentarium for patients with transplant-eligible newly diagnosed multiple myeloma.
Patient Case 1: Transplant-Eligible Newly Diagnosed Multiple Myeloma
Centering discussion on a patient case of transplant-eligible newly diagnosed multiple myeloma, expert panelists consider optimal workup and management strategies.
2 Clarke Drive Cranbury, NJ 08512